The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Mcgrane Nicholas since year 2005.
The trader's CIK number is 1643086.
At the time of this reporting, Mcgrane Nicholas is the Chief Financial Officer of Evolent Health, Inc. .
(stock ticker symbol EVH).
See this page for all insider trading activities at Evolent Health, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2017-07-10 | EVH | Evolent Health, Inc. | Option Ex | 1,667 | 3.84 | 6,401 |
| 2017-07-10 | EVH | Evolent Health, Inc. | Sale | 1,667 | 25.42 | 42,375 |
| 2017-06-12 | EVH | Evolent Health, Inc. | Option Ex | 1,667 | 3.84 | 6,401 |
| 2017-06-12 | EVH | Evolent Health, Inc. | Sale | 1,667 | 24.96 | 41,616 |
| 2017-06-07 | EVH | Evolent Health, Inc. | Sale | 10,000 | 27.01 | 270,100 |
| 2017-06-07 | EVH | Evolent Health, Inc. | Option Ex | 10,000 | 3.84 | 38,400 |
| 2017-06-06 | EVH | Evolent Health, Inc. | Sale | 495 | 25.75 | 12,746 |
| 2017-05-19 | EVH | Evolent Health, Inc. | Option Ex | 47,508 | 3.84 | 182,430 |
| 2017-05-19 | EVH | Evolent Health, Inc. | Sale | 47,508 | 24.30 | 1,154,444 |
| 2017-05-10 | EVH | Evolent Health, Inc. | Option Ex | 1,667 | 3.84 | 6,401 |
| 2017-05-10 | EVH | Evolent Health, Inc. | Sale | 1,667 | 24.28 | 40,474 |
| 2017-04-19 | EVH | Evolent Health, Inc. | Option Ex | 1,667 | 3.84 | 6,401 |
| 2017-04-19 | EVH | Evolent Health, Inc. | Sale | 1,667 | 22.52 | 37,540 |
| 2017-03-24 | EVH | Evolent Health, Inc. | Option Ex | 5,001 | 3.84 | 19,203 |
| 2017-03-24 | EVH | Evolent Health, Inc. | Sale | 7,034 | 22.50 | 158,265 |
| 2016-09-14 | EVH | Evolent Health, Inc. | Option Ex | 21,205 | 3.84 | 81,427 |
| 2016-09-14 | EVH | Evolent Health, Inc. | Sale | 21,205 | 21.54 | 456,755 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcgrane Nicholas (Chief Financial Officer of Evolent Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.